Spindle cell lipoma was first described by Enzinger and Harvey in 1975 (1) as a benign tumor usually occurring subcutaneously in the upper back, shoulder or posterior neck of middle-aged men, after which several other studies confirmed the existence of this lipoma subgroup (2) (3) (4) (5) (6) (7) (8) (9) . Their occurrence has also been reported in other sites such as the face, limbs, oral cavity, larynx, bronchus, orbit, breast, perianal region, and spermatic cord (10) . Macroscopically, spindle cell lipomas are mostly well circumscribed, round or discoid nodules. Histologically, they consist of a mixture of bland spindle cells and mature adipocytes. The matrix surrounding the cells is composed of varying amounts of mucoid material and collagen bundles haphazardly distributed throughout the lesion (1, 2, 4, 6) . Spindle cell lipomas can be challenging to the radiologist, pathologist, or surgeon to diagnose, particularly when they contain little internal fat (8) .
Pleomorphic lipomas were first described by Shmookler and Enzinger (11) . Like spindle cell lipomas, their most common location is in subcutaneous tissue of the shoulders and posterior neck of adults, especially men. They are solitary, circumscribed, slow-growing, painless tumors. Microscopically, they show admixture of mature adipose tissue and pleomorphic multinucleated cells, so-called florette cells, and overall display histological and immunophenotypic features similar to those of spindle cell lipomas (3, 4, 12) . Thus, this tumor type is now accepted as an extremely pleomorphic variant of spindle cell lipomas and the two are lumped together as spindle cell/pleomorphic lipoma (13) .
In 1994, Mandahl et al. (14) reported the cytogenetic findings in six spindle cell lipomas and two pleomorphic lipomas. One spindle cell lipoma had a supernumerary ring chromosome as the sole anomaly. The other five spindle cell lipomas and both pleomorphic lipomas had hypodiploid stemlines with monosomy 16 or unbalanced aberrations leading to loss of 16q13-qter. Unbalanced aberrations of chromosomes 13 and 10 were also found. In addition, both pleomorphic lipomas, but none of the spindle cell lipomas, had hypotetraploid sidelines, multiple nonclonal aberrations, and telomeric associations (14) . (14) (15) (16) (17) (18) (19) (20) . In addition, another two cases of spindle cell lipoma were reported in a French-language report (21) . By way of comparison, the same database contains information on altogether 490 karyotypically abnormal ordinary lipomas reported in 57 articles. The cytogenetic knowledge about spindle cell/pleomorphic lipomas based on these reports can be summarized as follows: in the majority of cases, the chromosome number is 44-46 and monosomies or partial chromosome losses are the dominating abnormalities. Chromosomes 13 and 16 are the most frequently affected with monosomy for or partial loss of chromosome 13 and deletion of 16q13-qter coming across as the most common aberrations (22) . We wanted to add to the cytogenetic knowledge on spindle cell/pleomorphic lipoma and for this reason present our data on another 31 tumors of this type.
Materials and Methods
Materials. Information about the patients' sex and age and the tumors' location, depth, and size is given in Table I . The patients were 25 males and 6 females. The age range was from 32 to 80 years, with a median of 58. In 26 patients, the diagnosis was spindle cell lipoma ( Figure 1A ), in one of them with a myxoid component, whereas the diagnosis was pleomorphic lipoma in 5 tumors ( Figure  1B) . Eleven of the tumors were located in the neck, five in the back, three in the shoulders, two in the thoracic wall, and two in the upper arm. Other tumors were found in the leg, flank, instep, knee, wrist, hand, and scalp.
The material for cytogenetic analysis consisted of 26 tumor resections and 7 tumor biopsies from 31 patients (2 tumors were examined first on biopsy material, later on resectates). They were diagnosed as spindle cell or pleomorphic lipoma at the Department of Pathology and cytogenetically analyzed at the Section for Cancer Cytogenetics, both at The Norwegian Radium Hospital, Oslo University Hospital, between 2002 and 2016. The study was approved by the regional ethics committee (Regional komité for medisinsk forskningsetikk Sør-Øst, Norge, http://helseforskning.etikkom.no). All patient information has been de-identified.
G-banding and karyotyping. Fresh tissues from a representative area of resected tumors (n=26) or core needle biopsies (n=7; two tumors were examined both as biopsies and resectates) were received and analyzed cytogenetically as part of our diagnostic routine. The samples were disaggregated mechanically and enzymatically with collagenase II (Worthington, Freehold, NJ, USA). The resulting cells were cultured and harvested using standard techniques (23) . Chromosome preparations were G-banded with Wright's stain (Sigma-Aldrich; St. Louis, MO, USA) and examined. Metaphases were analyzed and karyograms were prepared using the CytoVision computer assisted karyotyping system (Leica Biosystems, Newcastle, UK). The karyotypes were described according to the International System for Human Cytogenomic Nomenclature (24) .
Fluorescence in situ hybridization (FISH).
The following probes were used for FISH analysis: i) FOXO1 break apart rearrangement probe purchased from Cytocell (Cytocell, Cambridge, UK). This probe hybridizes to a 1.5 Mbp sequence on 13q14.11 which contains the FOXO1 gene. According to the company's information, it consists of two probes (405 kb and 183 kb), labelled in green, situated proximal to the FOXO1 gene and covering markers D13S765 and SHGC-111293, and four probes (123 kb, 142 kb, 95kb, and 253kb), labelled in red, situated distal to the FOXO1 gene and covering markers D13S638 and SHGC-16596. ii) RB1 deletion probe, purchased from Cytocell (Cytocell, Cambridge, UK) and used to detect deletion of the RB1 locus in 13q14.2. It consists of a 318 kb red probe spanning RB1 and a 13qter green probe acting as a control for chromosome 13. iii) A homemade break apart HMGA2 probe (25) . The 5'-end of the probe (red signal) was constructed from a pool of the clones RP11-185K16, RP11-30I11, and RP11-662G15. The 3'-end of the probe (green signal) was constructed from a pool of the clones RP118B13, RP11-745O10, and RP11-263A04. All of them map to chromosome subband 12q14.3 and cover the HMGA2 locus. Detailed information on the HMGA2 BAC clones is given elsewhere (25) . Fluorescent signals were captured and analyzed using the CytoVision system (Leica Biosystems, Newcastle, UK).
Results
Karyotyping. All the samples had cells carrying cytogenetic aberrations; during the same time period, only one other tumor with this diagnosis was subjected to cytogenetic [7] analysis but was found to have a normal karyotype (data not shown). Most of the tumors had pseudo-or near-diploid karyotypes, although two were near-triploid (cases 23 and 24) (Table I ). In two tumors (cases 17 and 23), only numerical changes were found whereas the rest had structural only or both structural and numerical aberrations. In cases 9 and 18, cytogenetic analysis was performed on both a tumor biopsy (a) and material from the resected tumor (b). In case 9, cytogenetically-different structural aberrations were found in the biopsy and the resection (Table I, 9a and  9b) , whereas the two samples in case 18 had the same karyotypes (Table I, 18a and 18b) . The most frequent aberrations (over 20%) involved numerical and/or structural changes of chromosomes 13, 6, 1, 12, and 11 (in decreasing order; Table I Figure 2 .
Changes of chromosome 6 were found in 13 tumors (42%). Seven of them had either loss of the entire copy (cases 21 and 23) or deletions in or of 6q (cases 2, 5, 9b, 10, 12, 26, and 27), while 6 tumors had structural aberrations targeting 6p21 (cases 12, 13, 27, 28, 30, and 31).
Chromosome 1 aberrations were seen in 8 tumors (26%), either as losses in the p-arm (case 3) or q-arm (cases 7 and 24) or as balanced rearrangements (cases 9b, 11, and 13-15). Changes of chromosome 12 were also found in 8 tumors; in the majority of them (cases 6, 11, 15, 16, 19, 21 , and 24), structural aberrations affected region 12q13~15, whereas 2 tumors (cases 6 and 17) had an extra copy of the chromosome. The partial karyotype showing the t(1;12)(p32;q15) for sample 1 is presented in Figure 2 . The arms of chromosome 11 were affected by structural aberrations in a total of 7 tumors (23%) (cases 1, 2, 9b, 19, 24, 26, and 28).
FISH.
The results of interphase FISH analyses with RB1 (13q14.2), 13qter, FOXO1 (13q14.11), and HMGA2 (12q14) probes are presented in Table II . The analyses could be performed on 13 samples (12 cases): eight cases with chromosome 13q aberrations (4, 9b, 12, 18a, 18b, 27, 29, and 30), one tumor with chromosome 13 and 12q changes (case 15), one tumor with 12q rearrangement (case 11), and three cases without aberrations of chromosomes 12 and 13 (14, 22, and 28) .
Heterozygous deletion of the RB1 probe was observed in seven cases: 9b, 12, 18a and 18b, 27, 29, and 30. In cases 9b and 27, heterozygous deletion of the 13qter probe was also found. Furthermore, in cases 9b, 12, 29, and 30, heterozygous deletion of FOXO1 was observed; in case 29, the deletion was partial. In contrast, cases 18a and 18b did not show deletions of FOXO1. Rearrangements of the HMGA2 gene were detected in cases 11 and 15. Cases 4, 14, 22, and 28 did not show any changes by FISH with the probes used. In Figure 2 FISH analyses are shown with FOXO1 break apart and RB1 deletion probes for samples 9b, 12, and 18b, and with an HMGA2 probe for sample 11.
Discussion
To the best of our knowledge, the present study describes the largest series of cytogenetically-abnormal spindle cell/ pleomorphic lipomas. Our findings show that structural CANCER GENOMICS & PROTEOMICS 15: 193-200 (2018) 196 Deletions of 13q or loss of chromosome 13 were also reported in ordinary lipomas with karyotypic aberrations, albeit less frequently (16, 17, 27, 28) . In the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 12 lipomas with -13 and 35 lipomas with del(13q) are listed (29) . Involvement of chromosome 13 was also found in cellular angiofibroma, extramammary myofibroblastoma, and recently in angiolipoma (30) (31) (32) . The morphologic similarities among cellular angiofibroma, extramammary myofibroblastoma, and spindle cell lipoma together with their cytogenetic similarities, in particular loss of material from the long arm of chromosome 13, suggest that these tumors arise through largely identical pathogenetic mechanisms from a common connective tissue precursor cell which then undergoes (myo)fibroblastic or adipocytic differentiation (30, 31, 33, 34) .
The results of interphase FISH analysis with RB1 and/or FOXO1 probes were in good overall agreement with the results of G-banding analysis (Tables I and II) . In four tumors without chromosome 13 changes (cases 11, 14, 22, and 28), no deletions of any probe were found. Neither was deletion of RB1 nor deletion of 13qter detected in case 4 which had a balanced t(13;14) involving 13q12. On the other hand, heterozygous deletion of the RB1 locus was observed in seven samples with 13q rearrangements or loss detected by Gbanding (cases 9b, 12, 18a, 18b, 27, 29, and 30); in five of these cases, the 13qter probe was retained. In the four cases (9b, 12, 29, and 30) with structural unbalanced aberrations involving 13q14, both RB1 and FOXO1 were deleted.
In the two samples of case 18, with a seemingly balanced t(5;13)(p15;q14) as the sole anomaly, heterozygous deletion of RB1 but not of FOXO1 and 13qter was found. The data indicate the presence of a submicroscopic deletion of the RB1 locus which in its turn suggests that RB1, or another gene very close, may be important in spindle cell/pleomorphic lipoma pathogenesis.
The fact is that the molecular target of chromosome 13 aberrations in spindle cell/pleomorphic lipomas, typical lipomas, cellular angiofibromas, extramammary myofibroblastoma, and angiolipoma remains unknown. Bartuma et al. (16) identified two minimal deleted regions (MDR) in 13q14 for spindle cell lipoma and one for typical lipomas. These deletions were associated with down-regulated expression of several genes. Because the expression levels of RB1 were not significantly reduced and because no mutations were seen by sequencing, the authors concluded that there is no decisive In our series, involvement of chromosome 12 was found in 26% of the tumors. Rearrangements of the bands 12q13-15 are the most common change in ordinary lipomas where they are found in two-thirds of all tumors with an abnormal karyotype (22) . The translocation t(1;12)(p32;q15), found in case 11 as the sole anomaly, has also been described in ordinary lipomas (29) , whereas the t(12;14)(q15;q24) found in case 16 is often found in uterine leiomyomas and chondroid hamartomas (29) . The target gene of the 12q13-15 rearrangements in benign connective tumors is HMGA2 (22) . Our FISH experiments confirmed the involvement of HMGA2 in cases 11 and 15 with 12q15 rearrangements; neither deletion of RB1 nor deletion of FOXO1 was found in these tumors.
Chromosome 16 was in the past reported as being frequently rearranged in spindle cell/pleomorphic lipomas (22) . Mandahl et al. (14) found unbalanced aberrations of chromosome 16 in 7 out of 8 examined spindle cell/pleomorphic lipomas. Bartuma et al. (16) reported chromosome 16 rearrangements in 9 out of 11 tumors and Dahlén et al. (17) found similar changes in 4 of 11 tumors. In our series, only 5 out of 31 tumors had a visible aberration of chromosome 16, and in four of them the aberration was seen together with changes of chromosome 13. In comparison, chromosomes 6, 1, 12, and 11 were involved more frequently (40-20% in decreasing order). Our data indicate that alternative genetic pathways exist for the development of spindle cell/pleomorphic lipomas, many of which are shared by other benign connective tissue tumors. However, the presence of submicroscopic deletions within 13q14 or rearrangements targeting the HMGA2 locus cannot be excluded as pathogenetically important in tumors without any microscopically visible changes of chromosomes 12 and 13.
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